Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4547084 | 0.94 | MEN1 (0.63) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL24641590 | 0.84 | KMT2A (0.41) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL18306783 | 0.82 | MEN1 (0.42) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL18830966 | 0.80 | MEN1 (0.85) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL10038045 | 0.80 | MEN1 (0.85) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL3187296 | 0.77 | USP2 (0.65) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL3187289 | 0.77 | USP2 (0.65) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL9851219 | 0.77 | KMT2A (0.53) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL3181075 | 0.77 | KMT2A (0.53) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL3187312 | 0.77 | CA12 (0.58) | MEN1KMT2AALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11643522-B2 | Polymer composition containing diarylamine-based compound | ZEON CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| EP-3590923-B1 | DIARYLAMINE-BASED COMPOUND, ANTI-AGING AGENT, AND POLYMER COMPOSITION | ZEON CORP (JP) | 2022-08-03 | — | — | EP | disclosed |
| US-20220127430-A1 | POLYMER COMPOSITION CONTAINING DIARYLAMINE-BASED COMPOUND | ZEON CORPORATION (JP) | 2022-04-28 | — | — | US | disclosed |
| US-11254802-B2 | Diarylamine-based compound, anti-aging agent, and polymer composition | ZEON CORPORATION (JP) | 2022-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127430-A1 | POLYMER COMPOSITION CONTAINING DIARYLAMINE-BASED COMPOUND | GPX1, GPX4, GSTA1 | MEN1 2151/4885KMT2A 1459/4885ALDH1A1 96/4885 |
| US-11643522-B2 | Polymer composition containing diarylamine-based compound | GPX1, GPX4, GSTA1 | MEN1 2151/4885KMT2A 1459/4885ALDH1A1 96/4885 |
| US-11254802-B2 | Diarylamine-based compound, anti-aging agent, and polymer composition | CCNA1, CCNA2, CDKN1A | MEN1 1982/4885KMT2A 1041/4885ALDH1A1 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.